First substantial mechanism for long term immunity from SARS-CoV-2 : T-cells

M. Leslie, “T cells found in COVID-19 patients ‘bode well’ for long-term immunity“, Science, doi:10.1126/science.abc8120.

A. Grifoni, et al, “Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals“, Cell, 14th May 2020.

J. Braun, L. Loyal, et al, “Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors“, medRχiv (not peer-reviewed, with comments), 22 April 2020.

34% of non-CV19 patients in Germany already had the Coronavirus spike protein specific helper T-cells. Due most likely to infection with prior common cold coronaviruses. That number is close to the percentage of “asymptomatic cases” we are seeing.

About ecoquant

See http://www.linkedin.com/in/deepdevelopment/ and https://667-per-cm.net/about
This entry was posted in American Association for the Advancement of Science, coronavirus, COVID-19, epidemiology, SARS-CoV-2 and tagged . Bookmark the permalink.

Leave a reply. Commenting standards are described in the About section linked from banner.

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.